Literature DB >> 10858646

Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi.

A C Frasch1.   

Abstract

Trypanosomes are unable to synthesize the monosaccharide sialic acid, but some African trypanosomes and the American Trypanosoma cruzi can incorporate sialic acid derived from the host. To do so, T. cruzi expresses a trans-sialidase, an enzyme that catalyzes the transfer of sialic acid from host glycoconjugates to mucin-like molecules located on the parasite surface membrane. The importance of the process is indicated by the fact that T. cruzi has hundreds of genes encoding trans-sialidase, trans-sialidase-like proteins and mucin core proteins. Sequence divergence of members of these families has resulted in some molecules having functions unrelated to the acquisition of sialic acid. In this article, Alberto Frasch reviews the structure and possible function of the proteins making up these families.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858646     DOI: 10.1016/s0169-4758(00)01698-7

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  91 in total

1.  Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.

Authors:  T A Pitcovsky; J Mucci; P Alvarez; M S Leguizamón; O Burrone; P M Alzari; O Campetella
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Gene discovery in the freshwater fish parasite Trypanosoma carassii: identification of trans-sialidase-like and mucin-like genes.

Authors:  Fernán Agüero; Vanina Campo; Laura Cremona; Adriana Jäger; Javier M Di Noia; Peter Overath; Daniel O Sánchez; Alberto Carlos Frasch
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

4.  Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.

Authors:  Vera Lucia Pereira-Chioccola; Abilio Augusto Fragata-Filho; Antonio Marcos de Apparecida Levy; Mauricio M Rodrigues; Sergio Schenkman
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 5.  Sialoglycans in protozoal diseases: their detection, modes of acquisition and emerging biological roles.

Authors:  Anil K Chava; Sumi Bandyopadhyay; Mitali Chatterjee; Chitra Mandal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Hyperosmotic stress induces aquaporin-dependent cell shrinkage, polyphosphate synthesis, amino acid accumulation, and global gene expression changes in Trypanosoma cruzi.

Authors:  Zhu-Hong Li; Vanina E Alvarez; Javier G De Gaudenzi; Celso Sant'Anna; Alberto C C Frasch; Juan J Cazzulo; Roberto Docampo
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

7.  Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.

Authors:  Paula A Sartor; Rosalía Agusti; Maria S Leguizamón; Oscar Campetella; Rosa M de Lederkremer
Journal:  Glycobiology       Date:  2010-04-07       Impact factor: 4.313

8.  Synthesis of PEGylated lactose analogs for inhibition studies on T.cruzi trans-sialidase.

Authors:  M Eugenia Giorgi; Laura Ratier; Rosalía Agusti; Alberto C C Frasch; Rosa M de Lederkremer
Journal:  Glycoconj J       Date:  2010-07-20       Impact factor: 2.916

9.  The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

Authors:  María Virginia Tribulatti; Juan Mucci; Nico Van Rooijen; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

10.  Synthesis of Galα(1,3)Galβ(1,4)GlcNAcα-, Galβ(1,4)GlcNAcα- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease.

Authors:  Nathaniel S Schocker; Susana Portillo; Carlos R N Brito; Alexandre F Marques; Igor C Almeida; Katja Michael
Journal:  Glycobiology       Date:  2015-09-18       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.